Canopy Growth ROE 2018-2025 | CGC
Current and historical return on equity (ROE) values for Canopy Growth (CGC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Canopy Growth ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.43B | $0.35B | -112.05% |
| 2024-12-31 | $-0.34B | $0.42B | -88.17% |
| 2024-09-30 | $-0.42B | $0.37B | -108.21% |
| 2024-06-30 | $-0.55B | $0.39B | -128.45% |
| 2024-03-31 | $-0.49B | $0.37B | -99.39% |
| 2023-12-31 | $-0.90B | $0.40B | -167.10% |
| 2023-09-30 | $-0.94B | $0.56B | -133.19% |
| 2023-06-30 | $-0.88B | $0.63B | -100.09% |
| 2023-03-31 | $-2.48B | $0.58B | -238.23% |
| 2022-12-31 | $-2.46B | $1.05B | -152.33% |
| 2022-09-30 | $-2.35B | $1.25B | -108.25% |
| 2022-06-30 | $-2.19B | $1.29B | -81.02% |
| 2022-03-31 | $-0.24B | $2.87B | -7.44% |
| 2021-12-31 | $-0.30B | $3.29B | -9.50% |
| 2021-09-30 | $-0.91B | $3.37B | -28.85% |
| 2021-06-30 | $-0.92B | $3.38B | -28.36% |
| 2021-03-31 | $-1.32B | $2.64B | -39.47% |
| 2020-12-31 | $-0.46B | $3.21B | -12.47% |
| 2020-09-30 | $0.15B | $3.81B | 3.78% |
| 2020-06-30 | $-0.11B | $3.74B | -2.80% |
| 2020-03-31 | $-0.99B | $3.84B | -23.79% |
| 2019-12-31 | $-1.59B | $4.19B | -34.55% |
| 2019-09-30 | $-1.44B | $4.26B | -29.18% |
| 2019-06-30 | $-1.42B | $4.41B | -33.49% |
| 2019-03-31 | $-0.52B | $5.52B | -15.48% |
| 2018-12-31 | $-0.32B | $5.61B | -14.36% |
| 2018-09-30 | $-0.37B | $1.41B | -35.92% |
| 2018-06-30 | $-0.11B | $0.95B | -13.79% |
| 2018-03-31 | $-0.06B | $0.97B | -7.68% |
| 2017-12-31 | $-0.02B | $0.80B | -3.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.230B | $0.226B |
| Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed brand. Canopy Growth Corporation is headquartered in Smiths Falls, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.470B | 25.39 |
| Boston Scientific (BSX) | United States | $153.537B | 38.44 |
| Stryker (SYK) | United States | $147.836B | 30.91 |
| EssilorLuxottica (ESLOY) | France | $131.607B | 0.00 |
| Medtronic (MDT) | Ireland | $115.044B | 16.31 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.188B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.812B | 24.44 |
| ResMed (RMD) | United States | $38.280B | 28.75 |
| GE HealthCare Technologies (GEHC) | United States | $33.957B | 16.12 |
| Agilent Technologies (A) | United States | $31.827B | 20.75 |
| Terumo (TRUMY) | Japan | $24.178B | 31.40 |
| Koninklijke Philips (PHG) | Netherlands | $23.630B | 16.58 |
| Insulet (PODD) | United States | $19.773B | 77.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.319B | 11.77 |
| Baxter (BAX) | United States | $14.046B | 10.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.647B | 23.13 |
| Lantheus Holdings (LNTH) | United States | $4.951B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.734B | 16.68 |
| Perrigo (PRGO) | Ireland | $3.704B | 9.39 |
| Haemonetics (HAE) | United States | $3.544B | 16.14 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.300B | 27.42 |
| ICU Medical (ICUI) | United States | $2.994B | 22.08 |
| LeMaitre Vascular (LMAT) | United States | $1.803B | 40.31 |
| QuidelOrtho (QDEL) | United States | $1.711B | 11.77 |
| AtriCure (ATRC) | United States | $1.448B | 0.00 |
| Acuren (TIC) | United States | $1.408B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.251B | 28.13 |
| AdaptHealth (AHCO) | United States | $1.235B | 12.53 |
| Phibro Animal Health (PAHC) | United States | $1.181B | 15.10 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| BioLife Solutions (BLFS) | United States | $0.993B | 0.00 |
| InMode (INMD) | Israel | $0.882B | 8.89 |
| Kestra Medical Technologies (KMTS) | United States | $0.854B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.831B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.678B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.606B | 0.00 |
| Owens & Minor (OMI) | United States | $0.598B | 4.96 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| CeriBell (CBLL) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.75 |
| Surmodics (SRDX) | United States | $0.446B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.305B | 11.22 |
| Cresco Labs (CRLBF) | United States | $0.302B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.286B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 78.33 |
| Cerus (CERS) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.256B | 21.57 |
| OraSure Technologies (OSUR) | United States | $0.243B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.228B | 60.45 |
| Biote (BTMD) | United States | $0.219B | 6.17 |
| Verano Holdings (VRNOF) | United States | $0.213B | 0.00 |
| Omeros (OMER) | United States | $0.213B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.151B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 14.99 |
| TerrAscend (TSNDF) | Canada | $0.121B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.82 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Safety Shot (SHOT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.87 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.038B | 51.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |